ATH

0.00%

0.5¢ alterity therapeutics limited

Dr Ira, page-3

First 3 Last

Share
Profile

Follow
xrx2gr0

1,560 Posts.

2

18/11/16

14:28

Post #: 20721272
Share

Originally posted by pjemmett ↑

An auditor friend likes to describe his role as akin to those who roam the battlefield after the battle and bayonet the wounded. In this spirit it might now be time to review the appointment, remuneration and contribution of Dr Ira Shoulson.
When appointed to the board on 13/05/2014 Ira was identified as an expert who had been a consultant to and member of several FDA advisory committees and had been involved in eight successful new drug applications to the FDA.
From the timing of this appointment (3 months after the Reach2HD results) It would be a fair assumption that Prana was already aware that the FDA might have an issue with the dog trials that were run in parallel with the HD trial, with this in mind Prana needed an expert in the workings of the FDA and IRA would have appeared to be the ideal person.
Since his appointment the good Dr has received up until 30 June 2016 a total of $A582747 in non-executive director and consultancy fees from Prana shareholders. That would have been money well spent if the results had been positive.
In my opinion it would be fair to assume that Prana have relied heavily on Ira’s advice and experience concerning the PCH and how best to resolve it to the FDA’s satisfaction.
Whatever advice Ira offered and whether it was followed or not is irrelevant as Prana has failed badly in its efforts to navigate the rocky waters of the FDA and get the PCH lifted, it has wasted the 2½ years since the Reach2HD results and we are now in a far worse position than we would have been if we had pursued a trial via the EMA.
It is difficult to see what value Dr Shoulson can continue to bring to Prana’s future efforts and as such I think his tenure as a director and consultant should be terminate in order to save funds and possibly assist in better strategic decisions being formulated. Perhaps we now need a EMA expert!
All of this is just my opinion.
PJ

Expand

"Perhaps we now need a EMA expert!"

Whatever happened to the new Acting Vice President of Business Development from Germany who was "hired" last spring but was not seen nor heard from again after one appearance on Prana's behalf at a European conference? Not a whisper from Prana. She could have become an EMA expert too in addition to bringing in all that new business (lol). Maybe she just didn't like Prana Biotech after a few days of getting to know them.

PBT Price at posting: 6.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

There are more pages in this discussion • 6 more messages in this thread...

First 3 Last

Add ATH (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $26.22M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$8.75K	1.75M

Buyers (Bids)

No.	Vol.	Price($)
59	63306661	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	28430837	21

View Market Depth

No.	Vol.	Price($)
57	62431661	0.004
47	46138652	0.003
17	39764402	0.002
13	92470101	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	28430837	21
0.006	34263249	13
0.007	22226649	17
0.008	14274594	13
0.009	6000000	5

Last trade - 16.10pm 12/07/2024 (20 minute delay)

ATH (ASX) Chart

Dr Ira, page-3

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Nimy to raise $1.21M to explore 'newsy' WA targets

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Dr Ira, page-3

Top Stories

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Nimy to raise $1.21M to explore 'newsy' WA targets

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News